What is the initial screening and treatment approach for a patient presenting with symptoms suggestive of inflammatory bowel disease (IBD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Screening for Inflammatory Bowel Disease

For patients aged 16-40 presenting with chronic lower gastrointestinal symptoms lasting >4 weeks, measure faecal calprotectin alongside basic laboratory tests, and refer urgently to gastroenterology for ileocolonoscopy if calprotectin is >250 μg/g. 1, 2

Primary Care Assessment

Essential History Components

  • Stool characteristics: frequency, consistency, presence of blood or mucus, urgency, nocturnal symptoms 1, 2
  • Systemic symptoms: fever, weight loss, malaise, fatigue 1, 2, 3
  • Red flag features: rectal bleeding with abdominal pain, change in bowel habit, iron deficiency anemia, abdominal/rectal/anal mass, unexplained anal ulceration 1, 2
  • Medication history: recent NSAID use (affects calprotectin interpretation), antibiotics, recent travel 1, 2
  • Smoking status and family history of IBD 1, 2
  • Extraintestinal manifestations: joint pain, skin changes, eye symptoms 1, 2

Physical Examination Findings

  • Vital signs: pulse rate (tachycardia suggests severe disease), blood pressure (hypotension indicates volume depletion), temperature (fever suggests complications), weight (compare to baseline) 1, 2
  • General appearance: assess for anemia, fluid depletion 1, 2
  • Abdominal examination: tenderness, distension, palpable masses 1, 2
  • Rectal examination: inspect for perianal disease, anal ulceration, masses 1, 2

Mandatory Initial Laboratory Testing

All patients must have the following tests in primary care: 1, 2

  • Complete blood count (assess for anemia, leukocytosis) 1, 2
  • Urea and electrolytes 1, 2
  • C-reactive protein (CRP) 1, 2
  • Coeliac serology 1, 2
  • Stool culture including Clostridium difficile toxin 1, 2

Faecal Calprotectin Interpretation and Action

Do not perform calprotectin testing if NSAID use within the past 6 weeks. 1

Calprotectin <100 μg/g

  • IBS is likely; treat as IBS in primary care 1
  • Consider other diagnoses if symptoms persist: bile acid malabsorption, microscopic colitis, medication effects 1
  • If IBD remains strongly suspected based on clinical features or family history, refer to gastroenterology despite low calprotectin 1, 2

Calprotectin 100-250 μg/g

  • Consider repeat testing or routine referral to gastroenterology 1
  • If strong clinical suspicion exists (red flag features, family history), proceed with urgent referral regardless of intermediate values 1, 2
  • This intermediate range is challenging to interpret as mild elevation may reflect non-specific low-grade inflammation 1

Calprotectin >250 μg/g

  • Refer urgently to gastroenterology for ileocolonoscopy 1, 2
  • Exclude infectious causes before referral 1

Critical Pitfalls to Avoid

  • Do not rely on CRP alone: approximately 15-20% of patients with active IBD have normal CRP levels 1, 2
  • Do not defer colonoscopy based on intermediate calprotectin if clinical suspicion is high: calprotectin should be interpreted in light of pre-test probability 1, 2
  • Do not delay assessment if systemically unwell: patients with suspected acute severe colitis require urgent inpatient assessment regardless of test results 1
  • Do not ignore red flag features: rectal bleeding with abdominal pain, unexplained weight loss, or palpable masses warrant immediate cancer pathway referral per NICE guidelines 1

Calprotectin Sampling Technique

Use the first stool passed in the morning and store for no more than 3 days at room temperature before analysis to minimize variation in calprotectin levels. 1

Secondary Care Diagnostic Workup

Once referred to gastroenterology:

Endoscopic Evaluation

  • Ileocolonoscopy with terminal ileal intubation is the reference standard 1, 2
  • Multiple biopsies from affected and normal-appearing areas, including terminal ileum 1, 2
  • For suspected Crohn's disease: document focal, asymmetric inflammation and skip lesions 1, 2
  • For ulcerative colitis: assess disease extent, look for loss of vascular pattern, granularity, friability, ulceration 1, 2

Cross-Sectional Imaging

  • MR enterography is essential at diagnosis to assess small bowel involvement and detect complications in Crohn's disease 2

Avoid Colonoscopy in Severe Colitis

  • In moderate to severe disease, flexible sigmoidoscopy is safer than colonoscopy due to higher perforation risk 1, 2
  • Colonoscopy in severe colitis should only be performed by experienced endoscopists with minimal air insufflation 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach to Suspected Inflammatory Bowel Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.